Indegene Limited
INDGN · 544172 · Healthcare · Healthcare Research, Analytics & Technology
Rs 555.8-14 (-2.46%)
- Market cap
- Rs 13,367 Cr
- P/E
- 33.26x
- P/B
- 4.26x
- 52W high / low
- Rs 596.8 / Rs 414
Our computed operating_margin (14.36%) diverges from BSE's own published figure (29.66%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
More
Peer comparison
Official BSE basic industry: Healthcare Research, Analytics & Technology. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Syngene International Limited | Rs 401.45 | Rs 16,174 Cr | Rs 3,809 Cr | Rs 317 Cr | 50.95x | 6.62% |
| Indegene LimitedThis company | Rs 555.8 | Rs 13,367 Cr | Rs 3,892 Cr | Rs 401 Cr | 33.26x | 10.39% |
| Suven Life Sciences Limited | Rs 342.35 | Rs 9,028 Cr | Rs 21 Cr | Rs -276.3 Cr | — | -78.80% |
| Vimta Labs Limited | Rs 617 | Rs 1,371 Cr | Rs 339 Cr | Rs 61.4 Cr | 46.29x | 20.41% |
| Median | Rs 586.4 | Rs 7,369 Cr | Rs 2,115 Cr | Rs 231 Cr | 39.77x | 15.40% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.
Loading stock details